{"id":24471,"date":"2020-07-08T14:48:15","date_gmt":"2020-07-08T18:48:15","guid":{"rendered":"https:\/\/www.bu.edu\/research\/?p=24471"},"modified":"2021-01-12T10:38:55","modified_gmt":"2021-01-12T15:38:55","slug":"call-for-proposals-pfizer-cti-2","status":"publish","type":"post","link":"https:\/\/www.bu.edu\/research\/2020\/07\/08\/call-for-proposals-pfizer-cti-2\/","title":{"rendered":"Call for Proposals: Pfizer CTI"},"content":{"rendered":"<p><span>We are pleased to announce a call for proposals for Pfizer\u2019s Centers for Therapeutic Innovation (CTI) program for collaborative development of novel biotherapeutics.<\/span><\/p>\n<p><strong>Deadline:<\/strong> September 21, 2020<\/p>\n<p><strong>Areas of Interest and Targets\/Pathways of Focus:<\/strong><\/p>\n<ol>\n<li>Opportunities related to DNA damage response and replicative stress in the context of nuclear or<br \/>\nspatial organization.<\/li>\n<li>Novel strategies targeting the cause or treatment of repeat expansion diseases<\/li>\n<li>Opportunities to target Cellular Senescence, including senolytic and senomomorphic approaches<\/li>\n<li>Opportunities related to Tissue-Immune System Crosstalk in disease pathology<\/li>\n<\/ol>\n<p><strong>Submission Process:\u00a0<\/strong>Submission entails a non-confidential 2-3 page overview of the target, mechanism, evidence for disease linkage, and the proposed therapeutic drug. At a high level, the pre-proposal should suggest how the therapeutic hypothesis could be tested in the clinic. Please submit non-confidential pre-proposals to Technology Development by September 21, 2020. For further information about submitting a pre-proposal, please contact Nevena Dimova at <a href=\"mailto:ndimova@bu.edu\">ndimova@bu.edu<\/a>.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: center;\"><a href=\"\/research\/files\/2020\/07\/CTI-Branded-2020-CFP-Flyer-BU.pdf\" class=\"button\">Request for Proposals<\/a><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: left;\">\n","protected":false},"excerpt":{"rendered":"<p>We are pleased to announce a call for proposals for Pfizer\u2019s Centers for Therapeutic Innovation (CTI) program for collaborative development of novel biotherapeutics. Deadline: September 21, 2020 Areas of Interest and Targets\/Pathways of Focus: Opportunities related to DNA damage response and replicative stress in the context of nuclear or spatial organization. Novel strategies targeting the [&hellip;]<\/p>\n","protected":false},"author":17607,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[225,426,247],"tags":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/posts\/24471"}],"collection":[{"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/users\/17607"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/comments?post=24471"}],"version-history":[{"count":2,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/posts\/24471\/revisions"}],"predecessor-version":[{"id":24504,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/posts\/24471\/revisions\/24504"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/media?parent=24471"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/categories?post=24471"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/tags?post=24471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}